Rectal Cancer Disappears After Experimental Use of Immunotherapy

12 patients with rectal cancer treated with dostarlimab - an anti PD1 monoclonal antibody with complete response. A very encouraging study for patients with stage 2/3 rectal cancer. More info here.

Previous post
Back to list
Next post